About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gimap5m1Btlr
mutation 1, Bruce Beutler
MGI:4456885
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gimap5m1Btlr/Gimap5m1Btlr either: (involves: BALB/cJ * C57BL/6J) or (involves: C3H/HeN * C57BL/6J) or (C57BL/6J * DBA/2J) or (involves: C57BL/6J * FVB/NJ) or (involves: C57BL/6J * NOD/ShiLtJ) MGI:4456988
hm2
Gimap5m1Btlr/Gimap5m1Btlr involves: C57BL/6J MGI:4456987
cx3
Gimap5m1Btlr/Gimap5m1Btlr
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
involves: C57BL/6J * DBA/2J MGI:4456989


Genotype
MGI:4456988
hm1
Allelic
Composition
Gimap5m1Btlr/Gimap5m1Btlr
Genetic
Background
either: (involves: BALB/cJ * C57BL/6J) or (involves: C3H/HeN * C57BL/6J) or (C57BL/6J * DBA/2J) or (involves: C57BL/6J * FVB/NJ) or (involves: C57BL/6J * NOD/ShiLtJ)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gimap5m1Btlr mutation (1 available); any Gimap5 mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• mice exhibit extramedullary hematopoiesis in the liver with foci of hematopoietic cells and hyperplastic nodules unlike wild-type mice

liver/biliary system
• mice exhibit extramedullary hematopoiesis in the liver with foci of hematopoietic cells and hyperplastic nodules unlike wild-type mice




Genotype
MGI:4456987
hm2
Allelic
Composition
Gimap5m1Btlr/Gimap5m1Btlr
Genetic
Background
involves: C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gimap5m1Btlr mutation (1 available); any Gimap5 mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• after 10 weeks, mice exhibit goblet cell depletion in the colon unlike in wild-type mice
• following PMA and ionomycin stimulation, B cells exhibit an increased percentage of B cells in the S phase and fewer in G2 phase compared with similarly treated wild-type cells
• LPS-stimulated B cells exhibit an increase in percentage of cells in the S phase compared with similarly treated wild-type cells
• however, proximal mitogenic signaling and cell cycle entry are normal
• B cells fail to proliferate after BCR stimulation, or treatment with the diacylglycerol mimetic, PMA, and the Ca++ mobilizing agent ionomycin unlike similarly treated wild-type mice
• however, B cell stimulated with LPS or CD40 exhibit normal proliferation

mortality/aging
• mice die by 14 weeks of age (J:160090)
• however, adoptive transfer of wild-type splenocytes reduces early mortality and adoptive transfer of Cd4, Cd8a, or Tcra-J null splenocytes prevents premature death (J:160090)

immune system
• by 14 weeks, mice exhibit intestinal inflammation unlike wild-type mice
• treatment with antibiotics ameliorates intestinal inflammation
• after 6 weeks, mice exhibit cell infiltration of the colon unlike wild-type mice
• after 10 weeks, mice exhibit severe colitis with goblet cell depletion, leukocyte infiltration into the lamina propria, epithelial cell hyperplasia, and crypt loss unlike wild-type mice
• mice exhibit thymus atrophy with age unlike wild-type mice
• however, adoptive transfer of wild-type splenocytes rescues thymus atrophy
• mice exhibit an increase in granulocyte numbers in the spleen compared with wild-type mice
• however, antibiotic treatment prevents accumulation of granulocytes
• mice exhibit lymphopenia unlike wild-type mice
• splenic B cells are decreased in number compared to in wild-type mice
• the number of mature B cell in the B cell compartment is reduced compared to in wild-type mice
• however, the percentages of marginal zone B cells and follicular B cells are normal
• near absent
• the number of invariant NK T cells is reduced with age unlike in wild-type mice
• reduced in size and number by P14 with granulocyte accumulation
• mice immunized with NP-CGG+alum+LPS or NP-ficoll fail to produce T-dependent antigen-specific IgG1 antibodies or T-independent antigen-specific IgM responses unlike similarly treated wild-type mice
• following PMA and ionomycin stimulation, B cells exhibit an increased percentage of B cells in the S phase and fewer in G2 phase compared with similarly treated wild-type cells
• LPS-stimulated B cells exhibit an increase in percentage of cells in the S phase compared with similarly treated wild-type cells
• however, proximal mitogenic signaling and cell cycle entry are normal
• B cells fail to proliferate after BCR stimulation, or treatment with the diacylglycerol mimetic, PMA, and the Ca++ mobilizing agent ionomycin unlike similarly treated wild-type mice
• however, B cell stimulated with LPS or CD40 exhibit normal proliferation
• mice exhibit a trend towards reduced Ig2a serum levels compared with wild-type mice
• alpha-Gal-Cer-stimulated invariant NK T cells produce no IFN-gamma and TNF-alpha and reduced IL4 compared with wild-type mice
• however, alpha-Gal-Cer-stimulated invariant NK T cells produce normal amounts of IL13
• following alpha-Gal-Cer stimulation
• following alpha-Gal-Cer stimulation
• in alpha-Gal-Cer-stimulated invariant NK T cells
• in alpha-Gal-Cer-stimulated invariant NK T cells
• in alpha-Gal-Cer-stimulated invariant NK T cells
• mice immunized with ovalbumin-expressing cells fail to reject adoptively transferred NK cells or CD8+ T cell target cells unlike similarly treated wild-type mice

digestive/alimentary system
• after 4 weeks in male mice
• after 10 weeks, mice exhibit epithelial cell hyperplasia in the colon unlike in wild-type mice
• after 10 weeks, mice exhibit crypt loss in the colon unlike in wild-type mice
• after 10 weeks, mice exhibit goblet cell depletion in the colon unlike in wild-type mice
• by 14 weeks, mice exhibit intestinal inflammation unlike wild-type mice
• treatment with antibiotics ameliorates intestinal inflammation
• after 6 weeks, mice exhibit cell infiltration of the colon unlike wild-type mice
• after 10 weeks, mice exhibit severe colitis with goblet cell depletion, leukocyte infiltration into the lamina propria, epithelial cell hyperplasia, and crypt loss unlike wild-type mice

liver/biliary system
N
• in culture, hepatocytes show no growth advantage and no dysplastic liver cells are observed
• mice exhibit normal liver metabolic function
• mice exhibit extramedullary hematopoiesis in the liver with foci of hematopoietic cells and hyperplastic nodules unlike wild-type mice

growth/size/body
• by 14 weeks, mice exhibit wasting unlike wild-type mice (J:160090)
• however, mice treated with antibiotics or adoptive transfer of wild-type, Cd4, Cd8a, or Tcra-J null splenocytes do not exhibit weight loss (J:160090)
• after 4 weeks in male mice
• after 6 weeks in female mice, less dramatic than in male mice

homeostasis/metabolism
• following alpha-Gal-Cer stimulation
• following alpha-Gal-Cer stimulation

endocrine/exocrine glands
• after 10 weeks, mice exhibit crypt loss in the colon unlike in wild-type mice
• after 10 weeks, mice exhibit goblet cell depletion in the colon unlike in wild-type mice
• mice exhibit thymus atrophy with age unlike wild-type mice
• however, adoptive transfer of wild-type splenocytes rescues thymus atrophy

hematopoietic system
• mice exhibit thymus atrophy with age unlike wild-type mice
• however, adoptive transfer of wild-type splenocytes rescues thymus atrophy
• mice exhibit extramedullary hematopoiesis in the liver unlike in wild-type mice
• however, adoptive transfer of wild-type splenocytes reduces extramedullary hematopoiesis
• mice exhibit normocytic anemia unlike wild-type mice
• however, adoptive transfer of wild-type splenocytes rescues anemia
• the number of megakaryocyte/erythroid progenitors in the bone marrow decline with age unlike in wild-type mice
• the numbers of megakaryocyte/erythroid and granulo-monocyte progenitors are increased in the liver compared to in wild-type mice
• however, the number of common lymphoid progenitors in the bone marrow is normal
• mice exhibit an increase in common myeloid progenitors (CMP) in the liver compared with wild-type mice
• however, adoptive transfer of wild-type splenocytes reduces splenic CMPs
• mice exhibit an increase in common lymphocyte progenitors (CLP) in the liver compared with wild-type mice
• however, adoptive transfer of wild-type splenocytes reduces splenic CLPs
• however, the number of common lymphoid progenitors in the bone marrow is normal
• mice exhibit an increase in granulocyte numbers in the spleen compared with wild-type mice
• however, antibiotic treatment prevents accumulation of granulocytes
• mice exhibit lymphopenia unlike wild-type mice
• splenic B cells are decreased in number compared to in wild-type mice
• the number of mature B cell in the B cell compartment is reduced compared to in wild-type mice
• however, the percentages of marginal zone B cells and follicular B cells are normal
• near absent
• the number of invariant NK T cells is reduced with age unlike in wild-type mice
• hematopoietic stem cells and hematopoietic precursors remained in the adult liver unlike in wild-type mice
• reduced in size and number by P14 with granulocyte accumulation
• mice immunized with NP-CGG+alum+LPS or NP-ficoll fail to produce T-dependent antigen-specific IgG1 antibodies or T-independent antigen-specific IgM responses unlike similarly treated wild-type mice
• following PMA and ionomycin stimulation, B cells exhibit an increased percentage of B cells in the S phase and fewer in G2 phase compared with similarly treated wild-type cells
• LPS-stimulated B cells exhibit an increase in percentage of cells in the S phase compared with similarly treated wild-type cells
• however, proximal mitogenic signaling and cell cycle entry are normal
• B cells fail to proliferate after BCR stimulation, or treatment with the diacylglycerol mimetic, PMA, and the Ca++ mobilizing agent ionomycin unlike similarly treated wild-type mice
• however, B cell stimulated with LPS or CD40 exhibit normal proliferation
• mice exhibit a trend towards reduced Ig2a serum levels compared with wild-type mice
• alpha-Gal-Cer-stimulated invariant NK T cells produce no IFN-gamma and TNF-alpha and reduced IL4 compared with wild-type mice
• however, alpha-Gal-Cer-stimulated invariant NK T cells produce normal amounts of IL13




Genotype
MGI:4456989
cx3
Allelic
Composition
Gimap5m1Btlr/Gimap5m1Btlr
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
Genetic
Background
involves: C57BL/6J * DBA/2J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gimap5m1Btlr mutation (1 available); any Gimap5 mutation (13 available)
Tg(TcraH-Y,TcrbH-Y)71Vbo mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• the number of H-Y-reactive thymocytes is decreased compared to in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• the number of H-Y TCR+ CD8+ thymocytes is decreased compared to in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• however, the number of H-Y TCR+ double positive thymocytes is normal
• the number of H-Y TCR+ CD8+ thymocytes is decreased compared to in Tg(TcraH-Y,TcrbH-Y)71Vbo mice

immune system
• the number of H-Y-reactive thymocytes is decreased compared to in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• the number of H-Y TCR+ CD8+ thymocytes is decreased compared to in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• however, the number of H-Y TCR+ double positive thymocytes is normal
• the number of H-Y TCR+ CD8+ thymocytes is decreased compared to in Tg(TcraH-Y,TcrbH-Y)71Vbo mice

endocrine/exocrine glands
• the number of H-Y-reactive thymocytes is decreased compared to in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• the number of H-Y TCR+ CD8+ thymocytes is decreased compared to in Tg(TcraH-Y,TcrbH-Y)71Vbo mice
• however, the number of H-Y TCR+ double positive thymocytes is normal





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory